{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T12:46:49Z","timestamp":1696942009915},"reference-count":89,"publisher":"American Society of Consultant Pharmacists","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2006,1,1]]},"DOI":"10.4140\/tcp.n.2006.58","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T02:09:46Z","timestamp":1294884586000},"page":"58-71","source":"Crossref","is-referenced-by-count":5,"title":["NonParkinsonism Movement Disorders in the Elderly"],"prefix":"10.4140","volume":"21","author":[{"given":"Jack J.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archneurpsyc.1922.02190120002001","article-title":"An essay on the shaking palsy, by James Parkinson, MD, Member of the Royal College of Surgeons","volume":"7","author":"A Ostheimer","year":"1922","journal-title":"Arch Neurol Psych"},{"key":"2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mds.870130105","article-title":"How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world.","volume":"13","author":"E Louis","year":"1998","journal-title":"Mov Disord"},{"key":"3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/jnnp.47.5.466","article-title":"Essential tremor in Rochester, Minnesota: a 45-year study","volume":"47","author":"A Rajput","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJMcp010928","article-title":"Essential tremor","volume":"345","author":"E Louis","year":"2001","journal-title":"N Engl J Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0404.1982.tb03129.x","article-title":"Essential tremor in a Finnish population","volume":"66","author":"I Rautakorpi","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"6","article-title":"Epidemiology and genetics of essential tremor.","volume":"13","author":"M Brin","year":"1998","journal-title":"Mov Disord"},{"key":"7","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.41.12.1982","article-title":"Is essential tremor benign","volume":"41","author":"K Busenbark","year":"1991","journal-title":"Neurology"},{"key":"8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004691-199603000-00004","article-title":"Central mechanisms of tremor","volume":"13","author":"R Elbe","year":"1996","journal-title":"J Clin Neurophysiol"},{"key":"9","article-title":"Consensus statement of the Movement Disorders Society on tremor.","volume":"13","author":"G Deuschl","year":"1998","journal-title":"Mov Disord"},{"key":"10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1212\/WNL.41.2_Part_1.234","article-title":"Essential tremor: clinical correlates in 350 patients","volume":"41","author":"J Lou","year":"1991","journal-title":"Neurology"},{"key":"11","first-page":"1","article-title":"Definitions and behavioral classifications","volume-title":"Handbook of tremor disorders","author":"L Findley","year":"1995"},{"key":"12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1592\/phco.23.10.1105.32750","article-title":"Essential tremor: diagnosis and treatment","volume":"23","author":"J Chen","year":"2003","journal-title":"Pharmacotherapy"},{"key":"13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0733-8619(05)70370-4","article-title":"Drug-induced movement disorders","volume":"16","author":"N Diederich","year":"1998","journal-title":"Neurol Clin"},{"key":"14","article-title":"The pathophysiology of essential tremor.","volume":"54","author":"G Deuschl","year":"2000","journal-title":"Neurology"},{"key":"15","article-title":"Functional imaging of tremor.","volume":"13","author":"H Boecker","year":"1998","journal-title":"Mov Disord."},{"key":"16","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1001\/archinte.160.16.2438","article-title":"Diagnosis and management of tremor","volume":"160","author":"H Rehman","year":"2000","journal-title":"Arch Intern Med"},{"key":"17","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor.","volume":"64","author":"T Zesiewicz","year":"2005","journal-title":"Neurology"},{"key":"18","first-page":"899","article-title":"Treatment du tremblement essential familial par le propranolol","volume":"102","author":"A Barbeau","year":"1962","journal-title":"Union Med Can"},{"key":"19","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.33.8.1076","article-title":"Nadolol in essential tremor","volume":"33","author":"W Koller","year":"1983","journal-title":"Neurology"},{"key":"20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1353-8020(03)00029-4","article-title":"A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor","volume":"9","author":"K Lee","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.44.8.677","article-title":"Effects of timolol and atenolol on benign essential tremor: placebo-controlled studies based on quantitative tremor recording","volume":"44","author":"P Dietrichson","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/jnnp.44.9.814","article-title":"Metoprolol and propranolol in essential tremor: a double-blind, controlled study","volume":"44","author":"S Calzetti","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/WNL.27.5.439","article-title":"Comparison between the effects of pindolol and propranolol on essential tremor","volume":"27","author":"H Teravainen","year":"1977","journal-title":"Neurology"},{"key":"24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00002826-199006000-00003","article-title":"Basic mechanisms of action of drugs used in the treatment of essential tremor","volume":"13","author":"X Guan","year":"1990","journal-title":"Clin Neuropharm"},{"key":"25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.36.7.1001","article-title":"Disability in essential tremor: effect of treatment","volume":"36","author":"W Koller","year":"1986","journal-title":"Neurology"},{"key":"26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/jnnp.51.3.379","article-title":"Propranolol and propranolol-LA in essential tremor: a double blind comparative study","volume":"51","author":"L Cleeves","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"27","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","article-title":"Acute and chronic effects of propranolol and primidone in essential tremor","volume":"39","author":"W Koller","year":"1989","journal-title":"Neurology"},{"key":"28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/bmj.282.6259.178","article-title":"Benign familial tremor treated with primidone","volume":"282","author":"M O'Brien","year":"1981","journal-title":"Br Med J"},{"key":"29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/jnnp.44.10.932","article-title":"Phenylethylmalonamide in essential tremor: a double blind controlled study","volume":"44","author":"S Calzetti","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jnnp.48.9.911","article-title":"Primidone in essential tremor of the hands and head: a double blind controlled clinical study","volume":"48","author":"L Findley","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archneur.56.4.475","article-title":"A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor","volume":"56","author":"A Gironel","year":"1999","journal-title":"Arch Neurol"},{"key":"32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0","article-title":"Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial","volume":"15","author":"W Ondo","year":"2000","journal-title":"Mov Disord"},{"key":"33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mds.870130315","article-title":"Double-blind controlled trial of gabapentin in essential tremor","volume":"13","author":"R Pahwa","year":"1998","journal-title":"Mov Disord"},{"key":"34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/1531-8249(200006)47:6<837::AID-ANA24>3.0.CO;2-2","article-title":"Topiramate and essential tremor","volume":"47","author":"N Galvez-Jimenez","year":"2000","journal-title":"Ann Neurol"},{"key":"35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.59.1.132","article-title":"A double-blind placebo-controlled trial of topiramate treatment for essential tremor","volume":"59","author":"G Connor","year":"2002","journal-title":"Neurology"},{"key":"36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00002826-200311000-00006","article-title":"Low doses of topiramate are effective in essential tremor: a report of three cases","volume":"26","author":"E Gatto","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"37","article-title":"A multicenter, double-blind, placebo-controlled trial of topiramate in essential tremor.","author":"J Jankovic","year":"2004","journal-title":"Mov Disord"},{"key":"38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2004.09.004","article-title":"Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol","volume":"11","author":"S Morita","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"39","first-page":"1466","article-title":"Zonisamide for the treatment of essential tremor: a case study.","volume":"25","author":"J Chen","year":"2005","journal-title":"Pharmacotherapy"},{"key":"40","volume-title":"A singleblind, open-label trial of sodium oxybate for myoclonus and essential tremor","author":"S Frucht","year":"2005"},{"key":"41","volume-title":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition (text revision)","year":"2000"},{"key":"42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/ajp.117.2.152","article-title":"Persistent muscular restlessness after phenothiazine treatment: report of 3 cases","volume":"117","author":"W Kruse","year":"1960","journal-title":"Am J Psychiatry"},{"key":"43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archpsyc.1996.01830040049009","article-title":"Incidence and correlates of tardive dyskinesia in first episode of schizophrenia","volume":"53","author":"M Chakos","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00004714-199102000-00005","article-title":"The prevalence of tardive dyskinesia","volume":"11","author":"M Woerner","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"45","first-page":"21","article-title":"Tardive dyskinesia rates with atypical antipsychotics in older adults.","volume":"65","author":"D Jeste","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"46","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/ajp.149.9.1206","article-title":"Tardive dyskinesia in elderly psychiatric patients: a 5-year study. Tardive dyskinesia in elderly psychiatric patients: a 5-year study.","volume":"149","author":"R Yassa","year":"1992","journal-title":"Am J Psychiatry"},{"key":"47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1982.04290040069010","article-title":"Tardive dyskinesia: prevalence and risk factors, 1959 to 1979","volume":"39","author":"J Kane","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"48","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/schbul\/18.4.701","article-title":"Gender differences in tardive dyskinesia: a critical review of the literature","volume":"18","author":"R Yassa","year":"1992","journal-title":"Schizophr Bull"},{"key":"49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies","volume":"161","author":"C Correll","year":"2004","journal-title":"Am J Psychiatry"},{"key":"50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4088\/JCP.v65n0305","article-title":"Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol","volume":"65","author":"M Dossenbach","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"51","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1532-5415.2005.53418.x","article-title":"Antipsychotic medications and druginduced movement disorders other than parkinsonism: a population-based cohort study in older adults","volume":"53","author":"P Lee","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"52","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archpsyc.1980.01780250054006","article-title":"Changes in prevalence, severity, and recovery in tardive dyskinesia with age","volume":"37","author":"J Smith","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"53","first-page":"125","article-title":"Tardive dyskinesia and depressive illness","volume":"2","author":"K Davis","year":"1976","journal-title":"Psychopharmacol Commun"},{"key":"54","first-page":"43","article-title":"Tardive dyskinesia in affective disorders.","volume":"60","author":"J Kane","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-440X(92)90008-E","article-title":"Increased tardive dyskinesia in alcohol-abusing schizophrenic patients","volume":"33","author":"L Dixon","year":"1992","journal-title":"Compr Psychiatry"},{"key":"56","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4088\/JCP.v64n0913","article-title":"Incidence of tardive dyskinesia in first-episode psychosis patients treated with lowdose haloperidol","volume":"64","author":"P Oosthuizen","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-004-1893-8","article-title":"Association of diabetes with dyskinesia in older psychosis patients","volume":"176","author":"M Caligiuri","year":"2004","journal-title":"Psychopharmacology (Berlin)"},{"key":"58","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1176\/ajp.150.6.966","article-title":"Diabetes and development of tardive dyskinesia","volume":"150","author":"M Woerner","year":"1993","journal-title":"Am J Psychiatry"},{"key":"59","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1176\/ajp.155.11.1521","article-title":"Prospective study of tardive dyskinesia in the elderly: rates and risk factors","volume":"155","author":"M Woerner","year":"1998","journal-title":"Am J Psychiatry"},{"key":"60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/j.1440-1614.2004.01382.x","article-title":"Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study","volume":"38","author":"P Sachdev","year":"2004","journal-title":"Aust N Z J Psychiatry"},{"key":"61","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1176\/ajp.155.4.565","article-title":"Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curacao Extrapyramidal Syndromes Study III","volume":"155","author":"P van Harten","year":"1998","journal-title":"Am J Psychiatry"},{"key":"62","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0006-3223(97)00453-8","article-title":"Tardive dyskinesia and serum iron indices","volume":"44","author":"D Wirshing","year":"1998","journal-title":"Biol Psychiatry"},{"key":"63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/00048679209072033","article-title":"Drug-induced movement disorders in institutionalised adults with mental retardation: clinical characteristics and risk factors","volume":"26","author":"P Sachdev","year":"1992","journal-title":"Aust N Z J Psychiatry"},{"key":"64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/brcg.1993.1046","article-title":"Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia","volume":"23","author":"E Pourcher","year":"1993","journal-title":"Brain Cogn"},{"key":"65","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archinte.153.12.1469","article-title":"The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders","volume":"153","author":"L Ganzini","year":"1993","journal-title":"Arch Intern Med"},{"key":"66","first-page":"65","article-title":"Dyskinetic phenomena in children treated with psychotropic medications","volume":"14","author":"P Polizos","year":"1978","journal-title":"Psychopharmacol Bull"},{"key":"67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1192\/bjp.181.2.135","article-title":"Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up","volume":"181","author":"R McCreadie","year":"2002","journal-title":"Br J Psychiatry"},{"key":"68","first-page":"10","article-title":"Prevalence of spontaneous dyskinesia in schizophrenia.","volume":"61","author":"W Fenton","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"69","first-page":"534","article-title":"Abnormal Involuntary Movements Scale (AIMS). ECDEU assessment manual for psychopharmacology.","author":"W Guy","year":"1976","journal-title":"United States Government Printing Office;"},{"key":"70","first-page":"51","article-title":"Reliability, validity, and a total score cutoff for the dyskinesia identification system: condensed user scale (DISCUS) with mentally ill and mentally retarded populations","volume":"27","author":"R Sprague","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00496058","article-title":"A rating scale for tardive dyskinesia","volume":"64","author":"G Simpson","year":"1979","journal-title":"Psychopharmacology (Berlin)"},{"key":"72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/106002809402800205","article-title":"How well do physicians, pharmacists, and psychologists assess tardive dyskinesia movements","volume":"28","author":"J Kalachnik","year":"1994","journal-title":"Ann Pharmacother"},{"key":"73","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/106002808802200305","article-title":"Pharmacybased screening program for tardive dyskinesia","volume":"22","author":"T Ahrens","year":"1988","journal-title":"Drug Intell Clin Pharm"},{"key":"74","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1192\/bjp.154.4.523","article-title":"The course of tardive dyskinesia in patients on long-term neuroleptics.","volume":"154","author":"J Bergen","year":"1989","journal-title":"Br J Psychiatry"},{"key":"75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0920-9964(01)00312-7","article-title":"Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder","volume":"57","author":"D Robinson","year":"2002","journal-title":"Schizophr Res"},{"key":"76","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.137.8.900","article-title":"Tardive dyskinesia: review and update","volume":"137","author":"H Klawans","year":"1980","journal-title":"Am J Psychiatry"},{"key":"77","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00702-004-0131-1","article-title":"Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias.","volume":"111","author":"J Kelley","year":"2004","journal-title":"J Neural Transm"},{"key":"78","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0447.1988.tb05138.x","article-title":"Tardive dyskinesia.","volume":"77","author":"J Gerlach","year":"1988","journal-title":"Acta Psychiatr Scand"},{"key":"79","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?","volume":"61","author":"O Andreassen","year":"2000","journal-title":"Prog Neurobiol"},{"key":"80","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0920-9964(02)00352-3","article-title":"Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements","volume":"62","author":"X Zhang","year":"2003","journal-title":"Schizophr Res"},{"key":"81","first-page":"1215","article-title":"Intermittent neuroleptic therapy and tardive dyskinesia: a literature review","volume":"35","author":"M Goldman","year":"1984","journal-title":"Hosp Community Psychiatry"},{"key":"82","year":"1992"},{"key":"83","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archpsyc.1982.04290070037008","article-title":"Therapeutic strategies against tardive dyskinesia","volume":"39","author":"D Jeste","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"84","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4088\/JCP.v65n0516","article-title":"A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia","volume":"65","author":"R Emsley","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"85","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1192\/bjp.157.4.585","article-title":"Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication","volume":"157","author":"W Glazer","year":"1990","journal-title":"Br J Psychiatry"},{"key":"86","first-page":"167","article-title":"A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia","volume":"57","author":"J Lohr","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"87","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1176\/ajp.149.6.773","article-title":"Treatment of tardive dyskinesia with vitamin E","volume":"149","author":"M Egan","year":"1992","journal-title":"Am J Psychiatry"},{"key":"88","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/mds.10705","article-title":"Unilateral deep brain stimulation of the internal globus pallidus alleviates tardive dyskinesia","volume":"19","author":"C Schrader","year":"2004","journal-title":"Mov Disord"},{"key":"89","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/jnnp.63.4.554a","article-title":"Bilateral posteroventral pallidotomy for severe antipsychotic induced tardive dyskinesia and dystonia","volume":"63","author":"J Weetman","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T20:04:59Z","timestamp":1559937899000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2006\/00000021\/00000001\/art00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,1]]}},"alternative-id":["DV17561629531561"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2006.58","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}